Hotchkiss et al. [64] tested BMS-936559, an anti–PD-L1 IgG4 antibody, in a phase Ib safety and tolerability study enrolling 24 patients with sepsis-associated immunosuppression. This evidence concerns the gene CD274 and Sepsis.